Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Market IntelliX Research, the global market for Molecular Point of Care (POC) should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Molecular Point of Care (POC) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Molecular Point of Care (POC) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Respiratory segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Clinical has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Molecular Point of Care (POC) include Abbott Laboratories, Aidian Oy, Akonni Biosystems, binx health, inc., Biocartis NV, bioMérieux SA, Cepheid, Credo Bioscience and Curetis NV, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Molecular Point of Care (POC). Report Highlights:
(1) Global Molecular Point of Care (POC) market size (value),history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Molecular Point of Care (POC) market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Molecular Point of Care (POC) market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Molecular Point of Care (POC) segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Molecular Point of Care (POC) segment by type and by application and regional segment by type and by application.
(6) Molecular Point of Care (POC) industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Respiratory
Other
Market segment by application, can be divided into
Clinical
Research
Market segment by players, this report covers
Abbott Laboratories
Aidian Oy
Akonni Biosystems
binx health, inc.
Biocartis NV
bioMérieux SA
Cepheid
Credo Bioscience
Curetis NV
DiaSorin S.p.A
GenMark Diagnostics
Greiner Bio-One GmbH
Meridian Bioscience, Inc.
Mesa Biotech, Inc.
QIAGEN NV
QuantuMDx Group
Quidel Corporation
Roche
Sekisui Diagnostics LLC
T2 Biosystems
1 Market Overview
1.1 Product Overview and Scope of Molecular Point of Care (POC)
1.2 Global Molecular Point of Care (POC) Market Size and Forecast
1.3 China Molecular Point of Care (POC) Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Molecular Point of Care (POC) Share in Global Market, 2019-2030
1.4.2 Molecular Point of Care (POC) Market Size: China VS Global, 2019-2030
1.5 Molecular Point of Care (POC) Market Dynamics
1.5.1 Molecular Point of Care (POC) Market Drivers
1.5.2 Molecular Point of Care (POC) Market Restraints
1.5.3 Molecular Point of Care (POC) Industry Trends
1.5.4 Molecular Point of Care (POC) Industry Policy
2 Global Competitive Situation by Company
2.1 Global Molecular Point of Care (POC) Revenue by Company (2019-2024)
2.2 Global Molecular Point of Care (POC) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Molecular Point of Care (POC) Concentration Ratio
2.4 Global Molecular Point of Care (POC) Mergers & Acquisitions, Expansion Plans
2.5 Global Molecular Point of Care (POC) Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Molecular Point of Care (POC) Revenue by Company (2019-2024)
3.2 China Molecular Point of Care (POC) Molecular Point of Care (POC) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Molecular Point of Care (POC), Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)
4 Industry Chain Analysis
4.1 Molecular Point of Care (POC) Industry Chain
4.2 Molecular Point of Care (POC) Upstream Analysis
4.3 Molecular Point of Care (POC) Midstream Analysis
4.4 Molecular Point of Care (POC) Downstream Analysis
5 Sights by Type
5.1 Molecular Point of Care (POC) Classification
5.1.1 Respiratory
5.1.2 Other
5.2 By Type, Global Molecular Point of Care (POC) Market Size & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global Molecular Point of Care (POC) Revenue, 2019-2030
6 Sights by Application
6.1 Molecular Point of Care (POC) Segment by Application
6.1.1 Clinical
6.1.2 Research
6.2 By Application, Global Molecular Point of Care (POC) Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global Molecular Point of Care (POC) Revenue, 2019-2030
7 Sales Sights by Region
7.1 By Region, Global Molecular Point of Care (POC) Market Size, 2019 VS 2024 VS 2030
7.2 By Region, Global Molecular Point of Care (POC) Market Size, 2019-2030
7.3 North America
7.3.1 North America Molecular Point of Care (POC) Market Size & Forecasts, 2019-2030
7.3.2 By Country, North America Molecular Point of Care (POC) Market Size Market Share
7.4 Europe
7.4.1 Europe Molecular Point of Care (POC) Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Molecular Point of Care (POC) Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Molecular Point of Care (POC) Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Molecular Point of Care (POC) Market Size Market Share
7.6 South America
7.6.1 South America Molecular Point of Care (POC) Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Molecular Point of Care (POC) Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Molecular Point of Care (POC) Market Size & CAGR,2019 VS 2024 VS 2030
8.2 By Country, Global Molecular Point of Care (POC) Market Size, 2019-2030
8.3 U.S.
8.3.1 U.S. Molecular Point of Care (POC) Market Size, 2019-2030
8.3.2 By Company, U.S. Molecular Point of Care (POC) Revenue Market Share, 2019-2024
8.3.3 By Type, U.S. Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.3.4 By Application, U.S. Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.4 Europe
8.4.1 Europe Molecular Point of Care (POC) Market Size, 2019-2030
8.4.2 By Company, Europe Molecular Point of Care (POC) Revenue Market Share, 2019-2024
8.4.3 By Type, Europe Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.4.4 By Application, Europe Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.5 China
8.5.1 China Molecular Point of Care (POC) Market Size, 2019-2030
8.5.2 By Company, China Molecular Point of Care (POC) Revenue Market Share, 2019-2024
8.5.3 By Type, China Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.5.4 By Application, China Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.6 Japan
8.6.1 Japan Molecular Point of Care (POC) Market Size, 2019-2030
8.6.2 By Company, Japan Molecular Point of Care (POC) Revenue Market Share, 2019-2024
8.6.3 By Type, Japan Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.6.4 By Application, Japan Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.7 South Korea
8.7.1 South Korea Molecular Point of Care (POC) Market Size, 2019-2030
8.7.2 By Company, South Korea Molecular Point of Care (POC) Revenue Market Share, 2019-2024
8.7.3 By Type, South Korea Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.7.4 By Application, South Korea Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Molecular Point of Care (POC) Market Size, 2019-2030
8.8.2 By Company, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2019-2024
8.8.3 By Type, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.8.4 By Application, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.9 India
8.9.1 India Molecular Point of Care (POC) Market Size, 2019-2030
8.9.2 By Company, India Molecular Point of Care (POC) Revenue Market Share, 2019-2024
8.9.3 By Type, India Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.9.4 By Application, India Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.10 Middle East & Asia
8.10.1 Middle East & Asia Molecular Point of Care (POC) Market Size, 2019-2030
8.10.2 By Company, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2019-2024
8.10.3 By Type, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
8.10.4 By Application, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2023 VS 2030
9 Global Manufacturers Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
9.1.2 Abbott Laboratories Company Profile and Main Business
9.1.3 Abbott Laboratories Molecular Point of Care (POC) Models, Specifications and Application
9.1.4 Abbott Laboratories Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.1.5 Abbott Laboratories Recent Developments
9.2 Aidian Oy
9.2.1 Aidian Oy Company Information, Head Office, Market Area and Industry Position
9.2.2 Aidian Oy Company Profile and Main Business
9.2.3 Aidian Oy Molecular Point of Care (POC) Models, Specifications and Application
9.2.4 Aidian Oy Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.2.5 Aidian Oy Recent Developments
9.3 Akonni Biosystems
9.3.1 Akonni Biosystems Company Information, Head Office, Market Area and Industry Position
9.3.2 Akonni Biosystems Company Profile and Main Business
9.3.3 Akonni Biosystems Molecular Point of Care (POC) Models, Specifications and Application
9.3.4 Akonni Biosystems Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.3.5 Akonni Biosystems Recent Developments
9.4 binx health, inc.
9.4.1 binx health, inc. Company Information, Head Office, Market Area and Industry Position
9.4.2 binx health, inc. Company Profile and Main Business
9.4.3 binx health, inc. Molecular Point of Care (POC) Models, Specifications and Application
9.4.4 binx health, inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.4.5 binx health, inc. Recent Developments
9.5 Biocartis NV
9.5.1 Biocartis NV Company Information, Head Office, Market Area and Industry Position
9.5.2 Biocartis NV Company Profile and Main Business
9.5.3 Biocartis NV Molecular Point of Care (POC) Models, Specifications and Application
9.5.4 Biocartis NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.5.5 Biocartis NV Recent Developments
9.6 bioMérieux SA
9.6.1 bioMérieux SA Company Information, Head Office, Market Area and Industry Position
9.6.2 bioMérieux SA Company Profile and Main Business
9.6.3 bioMérieux SA Molecular Point of Care (POC) Models, Specifications and Application
9.6.4 bioMérieux SA Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.6.5 bioMérieux SA Recent Developments
9.7 Cepheid
9.7.1 Cepheid Company Information, Head Office, Market Area and Industry Position
9.7.2 Cepheid Company Profile and Main Business
9.7.3 Cepheid Molecular Point of Care (POC) Models, Specifications and Application
9.7.4 Cepheid Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.7.5 Cepheid Recent Developments
9.8 Credo Bioscience
9.8.1 Credo Bioscience Company Information, Head Office, Market Area and Industry Position
9.8.2 Credo Bioscience Company Profile and Main Business
9.8.3 Credo Bioscience Molecular Point of Care (POC) Models, Specifications and Application
9.8.4 Credo Bioscience Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.8.5 Credo Bioscience Recent Developments
9.9 Curetis NV
9.9.1 Curetis NV Company Information, Head Office, Market Area and Industry Position
9.9.2 Curetis NV Company Profile and Main Business
9.9.3 Curetis NV Molecular Point of Care (POC) Models, Specifications and Application
9.9.4 Curetis NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.9.5 Curetis NV Recent Developments
9.10 DiaSorin S.p.A
9.10.1 DiaSorin S.p.A Company Information, Head Office, Market Area and Industry Position
9.10.2 DiaSorin S.p.A Company Profile and Main Business
9.10.3 DiaSorin S.p.A Molecular Point of Care (POC) Models, Specifications and Application
9.10.4 DiaSorin S.p.A Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.10.5 DiaSorin S.p.A Recent Developments
9.11 GenMark Diagnostics
9.11.1 GenMark Diagnostics Company Information, Head Office, Market Area and Industry Position
9.11.2 GenMark Diagnostics Company Profile and Main Business
9.11.3 GenMark Diagnostics Molecular Point of Care (POC) Models, Specifications and Application
9.11.4 GenMark Diagnostics Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.11.5 GenMark Diagnostics Recent Developments
9.12 Greiner Bio-One GmbH
9.12.1 Greiner Bio-One GmbH Company Information, Head Office, Market Area and Industry Position
9.12.2 Greiner Bio-One GmbH Company Profile and Main Business
9.12.3 Greiner Bio-One GmbH Molecular Point of Care (POC) Models, Specifications and Application
9.12.4 Greiner Bio-One GmbH Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.12.5 Greiner Bio-One GmbH Recent Developments
9.13 Meridian Bioscience, Inc.
9.13.1 Meridian Bioscience, Inc. Company Information, Head Office, Market Area and Industry Position
9.13.2 Meridian Bioscience, Inc. Company Profile and Main Business
9.13.3 Meridian Bioscience, Inc. Molecular Point of Care (POC) Models, Specifications and Application
9.13.4 Meridian Bioscience, Inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.13.5 Meridian Bioscience, Inc. Recent Developments
9.14 Mesa Biotech, Inc.
9.14.1 Mesa Biotech, Inc. Company Information, Head Office, Market Area and Industry Position
9.14.2 Mesa Biotech, Inc. Company Profile and Main Business
9.14.3 Mesa Biotech, Inc. Molecular Point of Care (POC) Models, Specifications and Application
9.14.4 Mesa Biotech, Inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.14.5 Mesa Biotech, Inc. Recent Developments
9.15 QIAGEN NV
9.15.1 QIAGEN NV Company Information, Head Office, Market Area and Industry Position
9.15.2 QIAGEN NV Company Profile and Main Business
9.15.3 QIAGEN NV Molecular Point of Care (POC) Models, Specifications and Application
9.15.4 QIAGEN NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.15.5 QIAGEN NV Recent Developments
9.16 QuantuMDx Group
9.16.1 QuantuMDx Group Company Information, Head Office, Market Area and Industry Position
9.16.2 QuantuMDx Group Company Profile and Main Business
9.16.3 QuantuMDx Group Molecular Point of Care (POC) Models, Specifications and Application
9.16.4 QuantuMDx Group Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.16.5 QuantuMDx Group Recent Developments
9.17 Quidel Corporation
9.17.1 Quidel Corporation Company Information, Head Office, Market Area and Industry Position
9.17.2 Quidel Corporation Company Profile and Main Business
9.17.3 Quidel Corporation Molecular Point of Care (POC) Models, Specifications and Application
9.17.4 Quidel Corporation Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.17.5 Quidel Corporation Recent Developments
9.18 Roche
9.18.1 Roche Company Information, Head Office, Market Area and Industry Position
9.18.2 Roche Company Profile and Main Business
9.18.3 Roche Molecular Point of Care (POC) Models, Specifications and Application
9.18.4 Roche Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.18.5 Roche Recent Developments
9.19 Sekisui Diagnostics LLC
9.19.1 Sekisui Diagnostics LLC Company Information, Head Office, Market Area and Industry Position
9.19.2 Sekisui Diagnostics LLC Company Profile and Main Business
9.19.3 Sekisui Diagnostics LLC Molecular Point of Care (POC) Models, Specifications and Application
9.19.4 Sekisui Diagnostics LLC Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.19.5 Sekisui Diagnostics LLC Recent Developments
9.20 T2 Biosystems
9.20.1 T2 Biosystems Company Information, Head Office, Market Area and Industry Position
9.20.2 T2 Biosystems Company Profile and Main Business
9.20.3 T2 Biosystems Molecular Point of Care (POC) Models, Specifications and Application
9.20.4 T2 Biosystems Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
9.20.5 T2 Biosystems Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Molecular Point of Care (POC) Market Size & CAGR: China VS Global, (US$ Million), 2019-2030
Table 2. Molecular Point of Care (POC) Market Restraints
Table 3. Molecular Point of Care (POC) Market Trends
Table 4. Molecular Point of Care (POC) Industry Policy
Table 5. Global Molecular Point of Care (POC) Revenue by Company (2019-2024) & (US$ million)
Table 6. Global Molecular Point of Care (POC) Revenue Market Share by Company (2019-2024)
Table 7. Global Molecular Point of Care (POC) Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Molecular Point of Care (POC) Mergers & Acquisitions, Expansion Plans
Table 9. Global Molecular Point of Care (POC) Manufacturers Product Type
Table 10. China Molecular Point of Care (POC) Revenue by Company (2019-2024) & (US$ million)
Table 11. China Molecular Point of Care (POC) Revenue Market Share by Company (2019-2024)
Table 12. Global Key Players of Molecular Point of Care (POC) Upstream (Raw Materials)
Table 13. Global Molecular Point of Care (POC) Typical Customers
Table 14. Molecular Point of Care (POC) Typical Distributors
Table 15. By Type, Global Molecular Point of Care (POC) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 16. By Application, Global Molecular Point of Care (POC) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 17. By Region, Global Molecular Point of Care (POC) Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 18. By Region, Global Molecular Point of Care (POC) Revenue, 2019-2030, US$ Million
Table 19. By Country, Global Molecular Point of Care (POC) Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 20. By Country, Global Molecular Point of Care (POC) Revenue, 2019-2030, US$ Million
Table 21. By Country, Global Molecular Point of Care (POC) Revenue Market Share, 2019-2030
Table 22. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
Table 23. Abbott Laboratories Company Profile and Main Business
Table 24. Abbott Laboratories Molecular Point of Care (POC) Models, Specifications and Application
Table 25. Abbott Laboratories Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 26. Abbott Laboratories Recent Developments
Table 27. Aidian Oy Company Information, Head Office, Market Area and Industry Position
Table 28. Aidian Oy Company Profile and Main Business
Table 29. Aidian Oy Molecular Point of Care (POC) Models, Specifications and Application
Table 30. Aidian Oy Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 31. Aidian Oy Recent Developments
Table 32. Akonni Biosystems Company Information, Head Office, Market Area and Industry Position
Table 33. Akonni Biosystems Company Profile and Main Business
Table 34. Akonni Biosystems Molecular Point of Care (POC) Models, Specifications and Application
Table 35. Akonni Biosystems Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 36. Akonni Biosystems Recent Developments
Table 37. binx health, inc. Company Information, Head Office, Market Area and Industry Position
Table 38. binx health, inc. Company Profile and Main Business
Table 39. binx health, inc. Molecular Point of Care (POC) Models, Specifications and Application
Table 40. binx health, inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 41. binx health, inc. Recent Developments
Table 42. Biocartis NV Company Information, Head Office, Market Area and Industry Position
Table 43. Biocartis NV Company Profile and Main Business
Table 44. Biocartis NV Molecular Point of Care (POC) Models, Specifications and Application
Table 45. Biocartis NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 46. Biocartis NV Recent Developments
Table 47. bioMérieux SA Company Information, Head Office, Market Area and Industry Position
Table 48. bioMérieux SA Company Profile and Main Business
Table 49. bioMérieux SA Molecular Point of Care (POC) Models, Specifications and Application
Table 50. bioMérieux SA Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 51. bioMérieux SA Recent Developments
Table 52. Cepheid Company Information, Head Office, Market Area and Industry Position
Table 53. Cepheid Company Profile and Main Business
Table 54. Cepheid Molecular Point of Care (POC) Models, Specifications and Application
Table 55. Cepheid Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 56. Cepheid Recent Developments
Table 57. Credo Bioscience Company Information, Head Office, Market Area and Industry Position
Table 58. Credo Bioscience Company Profile and Main Business
Table 59. Credo Bioscience Molecular Point of Care (POC) Models, Specifications and Application
Table 60. Credo Bioscience Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 61. Credo Bioscience Recent Developments
Table 62. Curetis NV Company Information, Head Office, Market Area and Industry Position
Table 63. Curetis NV Company Profile and Main Business
Table 64. Curetis NV Molecular Point of Care (POC) Models, Specifications and Application
Table 65. Curetis NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 66. Curetis NV Recent Developments
Table 67. DiaSorin S.p.A Company Information, Head Office, Market Area and Industry Position
Table 68. DiaSorin S.p.A Company Profile and Main Business
Table 69. DiaSorin S.p.A Molecular Point of Care (POC) Models, Specifications and Application
Table 70. DiaSorin S.p.A Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 71. DiaSorin S.p.A Recent Developments
Table 72. GenMark Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 73. GenMark Diagnostics Company Profile and Main Business
Table 74. GenMark Diagnostics Molecular Point of Care (POC) Models, Specifications and Application
Table 75. GenMark Diagnostics Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 76. GenMark Diagnostics Recent Developments
Table 77. Greiner Bio-One GmbH Company Information, Head Office, Market Area and Industry Position
Table 78. Greiner Bio-One GmbH Company Profile and Main Business
Table 79. Greiner Bio-One GmbH Molecular Point of Care (POC) Models, Specifications and Application
Table 80. Greiner Bio-One GmbH Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 81. Greiner Bio-One GmbH Recent Developments
Table 82. Meridian Bioscience, Inc. Company Information, Head Office, Market Area and Industry Position
Table 83. Meridian Bioscience, Inc. Company Profile and Main Business
Table 84. Meridian Bioscience, Inc. Molecular Point of Care (POC) Models, Specifications and Application
Table 85. Meridian Bioscience, Inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 86. Meridian Bioscience, Inc. Recent Developments
Table 87. Mesa Biotech, Inc. Company Information, Head Office, Market Area and Industry Position
Table 88. Mesa Biotech, Inc. Company Profile and Main Business
Table 89. Mesa Biotech, Inc. Molecular Point of Care (POC) Models, Specifications and Application
Table 90. Mesa Biotech, Inc. Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 91. Mesa Biotech, Inc. Recent Developments
Table 92. QIAGEN NV Company Information, Head Office, Market Area and Industry Position
Table 93. QIAGEN NV Company Profile and Main Business
Table 94. QIAGEN NV Molecular Point of Care (POC) Models, Specifications and Application
Table 95. QIAGEN NV Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 96. QIAGEN NV Recent Developments
Table 97. QuantuMDx Group Company Information, Head Office, Market Area and Industry Position
Table 98. QuantuMDx Group Company Profile and Main Business
Table 99. QuantuMDx Group Molecular Point of Care (POC) Models, Specifications and Application
Table 100. QuantuMDx Group Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 101. QuantuMDx Group Recent Developments
Table 102. Quidel Corporation Company Information, Head Office, Market Area and Industry Position
Table 103. Quidel Corporation Company Profile and Main Business
Table 104. Quidel Corporation Molecular Point of Care (POC) Models, Specifications and Application
Table 105. Quidel Corporation Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 106. Quidel Corporation Recent Developments
Table 107. Roche Company Information, Head Office, Market Area and Industry Position
Table 108. Roche Company Profile and Main Business
Table 109. Roche Molecular Point of Care (POC) Models, Specifications and Application
Table 110. Roche Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 111. Roche Recent Developments
Table 112. Sekisui Diagnostics LLC Company Information, Head Office, Market Area and Industry Position
Table 113. Sekisui Diagnostics LLC Company Profile and Main Business
Table 114. Sekisui Diagnostics LLC Molecular Point of Care (POC) Models, Specifications and Application
Table 115. Sekisui Diagnostics LLC Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 116. Sekisui Diagnostics LLC Recent Developments
Table 117. T2 Biosystems Company Information, Head Office, Market Area and Industry Position
Table 118. T2 Biosystems Company Profile and Main Business
Table 119. T2 Biosystems Molecular Point of Care (POC) Models, Specifications and Application
Table 120. T2 Biosystems Molecular Point of Care (POC) Revenue and Gross Margin, 2019-2024
Table 121. T2 Biosystems Recent Developments
List of Figure
Figure 1. Molecular Point of Care (POC) Picture
Figure 2. Global Molecular Point of Care (POC) Industry Market Size and Forecast (US$ million) & (2019-2030)
Figure 3. China Molecular Point of Care (POC) Revenue and Forecast (US$ million) & (2019-2030)
Figure 4. 2019-2030 China Molecular Point of Care (POC) Market Share of Global
Figure 5. Global Molecular Point of Care (POC) Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Molecular Point of Care (POC) Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024
Figure 7. China Molecular Point of Care (POC) Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Molecular Point of Care (POC) Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 9. Molecular Point of Care (POC) Industry Chain
Figure 10. Respiratory
Figure 11. Other
Figure 12. By Type, Global Molecular Point of Care (POC) Revenue, 2019-2030, US$ Million
Figure 13. By Type, Global Molecular Point of Care (POC) Revenue Market Share, 2019-2030
Figure 14. Clinical
Figure 15. Research
Figure 16. By Application, Global Molecular Point of Care (POC) Revenue, 2019-2030, US$ Million
Figure 17. By Application, Global Molecular Point of Care (POC) Revenue Market Share, 2019-2030
Figure 18. By Region, Global Molecular Point of Care (POC) Revenue Market Share, 2019-2030
Figure 19. North America Molecular Point of Care (POC) Revenue & Forecasts, 2019-2030, US$ Million
Figure 20. By Country, North America Molecular Point of Care (POC) Revenue Market Share, 2019-2024
Figure 21. Europe Molecular Point of Care (POC) Revenue & Forecasts, 2019-2030, US$ Million
Figure 22. By Country, Europe Molecular Point of Care (POC) Revenue Market Share, 2019-2024
Figure 23. Asia Pacific Molecular Point of Care (POC) Revenue & Forecasts, 2019-2030, US$ Million
Figure 24. By Country/Region, Asia Pacific Molecular Point of Care (POC) Revenue Market Share, 2019-2024
Figure 25. South America Molecular Point of Care (POC) Revenue & Forecasts, 2019-2030, US$ Million
Figure 26. By Country, South America Molecular Point of Care (POC) Revenue Market Share, 2019-2024
Figure 27. Middle East & Africa Molecular Point of Care (POC) Revenue & Forecasts, 2019-2030, US$ Million
Figure 28. U.S. Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)
Figure 29. By Company, U.S. Molecular Point of Care (POC) Market Share, 2019-2024
Figure 30. By Type, U.S. Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 31. By Application, U.S. Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 32. Europe Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)
Figure 33. By Company, Europe Molecular Point of Care (POC) Market Share, 2019-2024
Figure 34. By Type, Europe Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 35. By Application, Europe Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 36. China Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)
Figure 37. By Company, China Molecular Point of Care (POC) Market Share, 2019-2024
Figure 38. By Type, China Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 39. By Application, China Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 40. Japan Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)
Figure 41. By Company, Japan Molecular Point of Care (POC) Market Share, 2019-2024
Figure 42. By Type, Japan Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 43. By Application, Japan Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 44. South Korea Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)
Figure 45. By Company, South Korea Molecular Point of Care (POC) Market Share, 2019-2024
Figure 46. By Type, South Korea Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 47. By Application, South Korea Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 48. Southeast Asia Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)
Figure 49. By Company, Southeast Asia Molecular Point of Care (POC) Market Share, 2019-2024
Figure 50. By Type, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 51. By Application, Southeast Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 52. India Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)
Figure 53. By Company, India Molecular Point of Care (POC) Market Share, 2019-2024
Figure 54. By Type, India Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 55. By Application, India Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 56. Middle East & Asia Molecular Point of Care (POC) Revenue, 2019-2030, (US$ Million)
Figure 57. By Company, Middle East & Asia Molecular Point of Care (POC) Market Share, 2019-2024
Figure 58. By Type, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 59. By Application, Middle East & Asia Molecular Point of Care (POC) Revenue Market Share, 2022 VS 2029
Figure 60. Research Methodology
Figure 61. Breakdown of Primary Interviews
Figure 62. Bottom-up Approaches
Figure 63. Top-down Approaches
Research Methodology:
Molecular Point of Care (POC) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|